Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

130 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

NCT03066648

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health Sciences University Main Center Portland, Oregon, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
View Trial Details
Completed

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT

NCT04412811

Conditions
Cytomegalovirus Viremia, DNA Virus Infections, Hematologic Diseases, +6 more
Locations
  • Ospedale San Carlo Potenza, Italy
  • Policlinico GB Rossi Verona, Italy
  • UO Ematologia e TMO - Ospedale C. Panico Tricase, Lecce, Italy
  • A.O.U. Policlinico Federico II Naples, Napoli, Italy
View all 50 locations
View Trial Details
Completed

Evaluation of ClearLLab LS Screening Panel

NCT05819762

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • Tongji Hospital Wuhan, Hubei, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China
View Trial Details
Completed

Natural History Study for BEN

NCT00059423

Conditions
Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588

Conditions
Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, +18 more
Locations
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • Illinois Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View Trial Details

Related conditions